This HTML5 document contains 117 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://dx.doi.org/10.1111/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q42455896
rdf:type
wikibase:Item
schema:description
2009年論文 artigo científico naučni članak tudományos cikk teaduslik artikkel articolo scientifico 2009年论文 scientific article published on 22 June 2009 სამეცნიერო სტატია artigo científico научна статия наукова стаття, опублікована в червні 2009 wissenschaftlicher Artikel artykuł naukowy 2009年论文 artikel ilmiah artikull shkencor 2009 nî lūn-bûn 2009年论文 vedecký článok 2009年論文 מאמר מדעי мақолаи илмӣ bài báo khoa học artigo científico scientific article published on 22 June 2009 επιστημονικό άρθρο vitenskapelig artikkel 2009年论文 artículo científico publicado en 2009 2009年の論文 article científic article scientifique scientific article published on 22 June 2009 artículu científicu espublizáu en 2009 บทความทางวิทยาศาสตร์ article scientific научная статья 2009年论文 2009年論文 artikulong pang-agham videnskabelig artikel 2009年论文 articol științific vitskapeleg artikkel 2009年論文 مقالة علمية نشرت في 22 يونيو 2009 научни чланак ২২ জুন ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ tieteellinen artikkeli vědecký článek vetenskaplig artikel bilimsel makale научни чланак 2009年論文 wetenschappelijk artikel scienca artikolo 2009년 논문
p:P577
wds:Q42455896-A55BA685-FFE1-4A63-9A10-D8EF2688DA18
wdt:P577
2009-06-22T00:00:00Z
p:P2860
wds:Q42455896-900C6B5B-4FAB-4DF2-B7FE-528B443E0A1C wds:Q42455896-0B76D203-A038-4B69-AFD2-F0CAF6A68186 wds:Q42455896-4C0CC954-CFB4-4362-809A-91F3306C2AB7 wds:Q42455896-FDA0B56A-D075-4895-B07B-0915D166D275 wds:Q42455896-D238F510-563B-4993-92DD-018E110FC82D wds:Q42455896-E317304A-F3D0-474E-ADFD-62D5E4F8EDCB
wdt:P2860
wd:Q34617892 wd:Q35581001 wd:Q44456773 wd:Q46315882 wd:Q57450326 wd:Q43749401
p:P2093
wds:Q42455896-FCBB7530-DBAD-4AAF-95B3-8141B9C45F68 wds:Q42455896-FD3A8B85-0430-4DA4-8FDF-A073A8B2457D wds:Q42455896-AD08C94B-E1EE-4780-8A91-0A8D6AF946C8 wds:Q42455896-7399E40C-BCFC-48DC-BDEE-A56833C9877C wds:Q42455896-364507E0-C13C-47D9-AFD7-37DE1FDFC0C7 wds:Q42455896-0CF8F41B-209C-4D71-8842-E1080ACD4877
wdt:P2093
Jose Placer Juan Morote Enrique Trilla Carles Raventós Jacques Planas Carles Salvador
rdfs:label
Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis. Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis.
skos:prefLabel
Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis. Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis.
schema:name
Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis. Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis.
p:P50
wds:Q42455896-E3A17427-9354-4376-BC58-C0A6A002833D wds:Q42455896-F0E23510-2F0C-4C54-A912-6D9ED0CC60FB wds:Q42455896-B509B99F-E2AA-45BF-BE31-038995CB23AF
wdt:P50
wd:Q57589064 wd:Q64517911 wd:Q55445994
p:P1476
wds:Q42455896-E1ECF4FA-933C-4418-9D70-6F21A7FC20DA
wdt:P1476
Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis
p:P304
wds:Q42455896-4416FBD2-87E6-4C69-8F7D-62C69099CAD5
wdt:P304
1637-1640
p:P31
wds:Q42455896-5AA7D9F9-BD1A-493F-90D2-FAB0B29A110C
wdt:P31
wd:Q13442814
p:P921
wds:Q42455896-7AFB467E-C656-49B8-95D5-B12B87241D73
wdt:P921
wd:Q165328
p:P698
wds:Q42455896-4EFA3543-3F49-4B5E-8A34-4C40B35B7181
wdtn:P698
n12:19549260
wdt:P698
19549260
p:P1433
wds:Q42455896-33D1F143-8422-483A-A515-06A3B7821CC4
wdt:P1433
wd:Q4835773
p:P433
wds:Q42455896-ED09DB5F-9F9C-4E2F-9F93-2613613A5FF0
p:P478
wds:Q42455896-6B53D15F-B4BD-43B9-8917-A5197D6B1F99
wdt:P433
11
wdt:P478
104
p:P356
wds:Q42455896-AA1E8AF6-84A7-47E4-BC9C-DC6A09E8C89D
wdtn:P356
n11:J.1464-410X.2009.08622.X
wdt:P356
10.1111/J.1464-410X.2009.08622.X